04/02/2026
A Consortium-Oriented Call to Academic and Translational Research Communities
G Biological Products (GBP) provides standardized snake and scorpion venoms as a research-enabling infrastructure for Horizon Europe, TÜBİTAK, NIH, and EU-funded collaborative projects focused on toxinology, antivenom development, and venom-based translational research.
Our venom production systems operate under WHO-aligned ethical sourcing, traceability, and characterization frameworks, and are supported by species authentication, batch-level documentation, and predefined quality control parameters. This ensures data reproducibility, cross-partner comparability, and regulatory-aware use across multi-center research consortia.
Within funded research programs, GBP venom resources are suitable for integration into:
• Work Packages focused on antivenom development, preclinical neutralization, and comparative efficacy studies,
• Reference venom generation, standard setting, and venom biobanking activities,
• Mechanistic toxinology, pharmacology, and target validation studies,
• Doctoral, postdoctoral, and capacity-building components of large-scale collaborative projects.
GBP contributes as a non-academic research infrastructure and industrial partner, supporting consortia with standardized biological inputs, documentation-driven workflows, and long-term supply continuity. Our role is to reduce biological variability and enable robust translational outputs aligned with public funding expectations.
Consortium-ready research infrastructure | Standardized venom supply | Publicly funded collaboration
———
Consortium-Ready Structure
WP2 – Standardized Venom Production & Characterization
Objective: Establish reproducible, traceable, and quality-documented venom inputs for consortium-wide use.
GBP Contribution:
• WHO-aligned ethical sourcing and traceability
• Species authentication & geographical provenance
• Batch-level documentation and QC parameters
Outcome: Reduced biological variability; harmonized inputs across partners.
⸻
WP3 – Preclinical Evaluation & Translational Use
Objective: Enable cross-center comparability in antivenom and toxin-based research.
GBP Contribution:
• Venoms suitable for preclinical neutralization and potency studies
• Reference venom support for comparative efficacy assessments
• Materials aligned with regulated research environments
Outcome: Robust, comparable datasets supporting translational readiness.
⸻
WP4 – Reference Venom & Biobanking Infrastructure
Objective: Build sustainable reference standards and long-term research assets.
GBP Contribution:
• Standardized venom inputs for reference programs
• Support for venom biobanking and long-term storage strategies
• Documentation-driven continuity of supply
Outcome: Long-term research reproducibility and standard-setting capacity.
⸻
Expected Impact
• Strengthened scientific reproducibility in venom-based research
• Accelerated antivenom development pipelines
• Improved translation from toxinology to clinical relevance
• Enhanced consortium credibility in public funding evaluations
⸻
Exploitation & Sustainability
• Use of standardized venoms as validated research inputs beyond project lifetime
• Support for follow-up grants, regulatory-facing studies, and scale-up research
• Positioning GBP as a long-term infrastructure partner
⸻
Dissemination & Communication
• Joint publications and conference contributions
• Consortium-level visibility in toxinology and translational medicine networks
• Contribution to standardization discourse (reference venom frameworks)
